Hospital General Universitari de València
Hospital
Location:
València,
Spain (ES)
ISNI: 000000041770977X
ROR: https://ror.org/03sz8rb35
Show on Map:
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial (2023)
Lorusso D, Mouret-Reynier MA, Harter P, Cropet C, Caballero C, Wolfrum-Ristau P, Satoh T, et al.
Journal article
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy (2021)
Dietz J, Di Maio VC, de Salazar A, Merino D, Vermehren J, Paolucci S, Kremer A, et al.
Journal article
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020)
González-Serna D, Ochoa E, López-Isac E, Julià A, Degenhardt F, Ortego-Centeno N, Radstake TR, et al.
Journal article
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways (2019)
López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, et al.
Journal article
PEDIA: prioritization of exome data by image analysis (2019)
Hsieh TC, Mensah MA, Pantel JT, Aguilar D, Bar O, Bayat A, Becerra-Solano L, et al.
Journal article